Sarepta Therapeutics | SRPT - EPS Earnings Per Share


Sarepta Therapeutics reported $0.13 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 0.13 0.23 -0.13 Nov/05
FY2026Q2 Jun/2026 0.64 0.21 2.02 Aug/05
FY2026Q1 Mar/2026 3.16 1.11 -3.42 May/06
FY2025Q4 Dec/2025 -3.58 -1.27 1.90 Feb/25
FY2025Q3 Sep/2025 -0.13 -0.6 0.62 Nov/03




Eps Change Date
Acadia Pharmaceuticals USD 0.31 0.13 Sep/2026
Agios Pharmaceuticals USD -1.09 0.6 Sep/2026
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
Amgen USD 6.45 0.16 Sep/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
Biogen USD 2.62 0.98 Sep/2026
BioMarin Pharmaceutical USD 0.23 0.97 Sep/2026
Capricor Therapeutics USD -0.62 0.08 Dec/2025
Daiichi Sankyo JPY 45.5 7.78 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
Incyte USD -3.6 6.69 Sep/2026
Insmed USD -0.46 0.4 Sep/2026
Ionis Pharmaceuticals USD 0.66 1.35 Sep/2026
Moderna USD 0.38 2.35 Sep/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Neurocrine Biosciences USD 3.29 0.44 Sep/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.87 0.1 Sep/2026
PTC Therapeutics USD -0.62 1.54 Sep/2026
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 3.55 1.46 Sep/2026
Sarepta Therapeutics USD 0.13 0.51 Sep/2026
Tectonic Therapeutic USD -1.18 0.17 Jun/2026
Ultragenyx Pharmaceutical USD -1.16 0.26 Sep/2026
Vertex Pharmaceuticals USD 4.76 0.03 Sep/2026